25D-NBOMe Dosage Guide

LD50 has not yet been determined. Due to 25D-NBOMe's extreme potency, it should not be insufflated (snorted) as this method of administration appears to have led to several deaths from other NBOMe compounds in the past year. It is strongly recommended that one use harm reduction practices when using this substance. In terms of its addictive potential, 25D-NBOMe has not been studied formally but many users experience a self-regulating quality. Also, due to its immediate tolerance build up, which lasts up to 2 - 3 weeks after the experience, it is difficult to use this substance compulsively. 25D-NBOMe presents cross-tolerance with Cross-all psychedelics, meaning that after the consumption of 25D-NBOMe all psychedelics will have a reduced effect. - Overdose - **Austria:** 25D-NBOMe is illegal to possess, produce and sell under the NPSG (Neue-Psychoaktive-Substanzen-Gesetz Österreich). - **Brazil:** Possession, production and sale is illegal as it is listed on Portaria SVS/MS nº 344. - **Germany:** 25D-NBOMe is controlled under the NpSG (New Psychoactive Substances Act) as of November 26, 2016. Production and import with the aim to place it on the market, administration to another person and trading is punishable. Possession is illegal but not penalized. - **Japan:** 25D-NBOMe is a controlled substance in Japan effective March 25th, 2015. - **Sweden:** 25D-NBOMe is classed as Schedule I. - **Switzerland:** 25D-NBOMe is a controlled substance specifically named under Verzeichnis E. - Turkey:** 25D-NBOMe is a classed as drug and is illegal to possess, produce, supply, or import. - United Kingdom:** 25D-NBOMe is a Class A drug in the United Kingdom as a result of the N-benzylphenethylamine catch-all clause. - **Latvia:** 25D-NBOMe is a Schedule I controlled substance. - **Canada:** 25D-NBOMe would be considered Schedule III as it is a derivative of 2,5-dimethoxyphenethylamine. - Res